Literature DB >> 19425086

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Gregory M Pontone1, James R Williams, Karen E Anderson, Gary Chase, Susanne A Goldstein, Stephen Grill, Elaina S Hirsch, Susan Lehmann, John T Little, Russell L Margolis, Peter V Rabins, Howard D Weiss, Laura Marsh.   

Abstract

Anxiety disorders are common in Parkinson's disease (PD), but are not well characterized. This study determined the prevalence and clinical correlates of all DSM-IV-TR anxiety disorder diagnoses in a sample of 127 subjects with idiopathic PD who underwent comprehensive assessments administered by a psychiatrist and neurologist. A panel of six psychiatrists with expertise in geriatric psychiatry and/or movement disorders established by consensus all psychiatric diagnoses. Current and lifetime prevalence of at least one anxiety disorder diagnosis was 43% (n = 55) and 49% (n = 63), respectively. Anxiety disorder not otherwise specified, a DSM diagnosis used for anxiety disturbances not meeting criteria for defined subtypes, was the most common diagnosis (30% lifetime prevalence, n = 38). Compared with nonanxious subjects, panic disorder (n = 13) was associated with earlier age of PD onset [50.3 (12.2) vs. 61.0 (13.7) years, P < 0.01], higher rates of motor fluctuations [77% (10/13) vs. 39% (25/64), P = 0.01] and morning dystonia [38% (5/13) vs. 13% (8/62), P < 0.03]. This high prevalence of anxiety disorders, including disturbances often not meeting conventional diagnostic criteria, suggests that anxiety in PD is likely underdiagnosed and undertreated and refined characterization of anxiety disorders in PD is needed. In addition, certain anxiety subtypes may be clinically useful markers associated with disease impact in PD. 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19425086      PMCID: PMC2830642          DOI: 10.1002/mds.22611

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Anxiety disorders in familial parkinsonism.

Authors:  E C Lauterbach; R C Duvoisin
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

2.  The locus ceruleus and anxiety disorders in demented and nondemented familial parkinsonism.

Authors:  E C Lauterbach
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

3.  Anxiety and motor performance in Parkinson's disease.

Authors:  E R Siemers; A Shekhar; K Quaid; H Dickson
Journal:  Mov Disord       Date:  1993-10       Impact factor: 10.338

4.  Best estimate of lifetime psychiatric diagnosis: a methodological study.

Authors:  J F Leckman; D Sholomskas; W D Thompson; A Belanger; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1982-08

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

7.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

8.  Anxiety disorders in patients with Parkinson's disease.

Authors:  M B Stein; I J Heuser; J L Juncos; T W Uhde
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

9.  Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.

Authors:  R Henderson; R Kurlan; J M Kersun; P Como
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

10.  Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.

Authors:  R A Maricle; J G Nutt; J H Carter
Journal:  Mov Disord       Date:  1995-05       Impact factor: 10.338

View more
  73 in total

1.  Parkinson disease: Depression and anxiety in Parkinson disease.

Authors:  Pablo Martínez-Martín; Javier Damián
Journal:  Nat Rev Neurol       Date:  2010-05       Impact factor: 42.937

Review 2.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 3.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

4.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

Authors:  Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub
Journal:  Mov Disord       Date:  2020-06-10       Impact factor: 10.338

5.  Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD).

Authors:  Olie Westheimer; Cynthia McRae; Claire Henchcliffe; Arman Fesharaki; Sofya Glazman; Heather Ene; Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2015-04-03       Impact factor: 3.575

6.  The association between clinically relevant anxiety and other non-motor symptoms in Parkinson's disease.

Authors:  Si-Ming Jiang; Yong-Sheng Yuan; Qing Tong; Li Zhang; Qin-Rong Xu; Jian Ding; Ke-Zhong Zhang
Journal:  Neurol Sci       Date:  2015-07-08       Impact factor: 3.307

Review 7.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

8.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

9.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

10.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.